Structures by: Zolotarev P. N.
Total: 4
Bis[2,6-bis(1<i>H</i>-benzimidazol-2-yl-κ<i>N</i>^3^)pyridine-κ<i>N</i>]nickel(II) sulfate
C38H26N10Ni2,O4S2
Acta Crystallographica Section C (2018) 74, 3
a=9.8015(6)Å b=20.9572(15)Å c=21.7012(17)Å
α=90° β=90° γ=90°
Bis[2,6-bis(1<i>H</i>-benzimidazol-2-yl-κ<i>N</i>^3^)pyridine-κ<i>N</i>]nickel(II) sulfate
C38H26N10Ni2,O4S2
Acta Crystallographica Section C (2018) 74, 3
a=28.596(2)Å b=28.596(2)Å c=13.5438(9)Å
α=90° β=90° γ=90°
Bis[2,6-bis(1<i>H</i>-benzimidazol-2-yl-κ<i>N</i>^3^)pyridine-κ<i>N</i>]nickel(II) sulfate—–dimethylformamide—–water (1/1/4.25)
C38H26N10Ni2,O4S2,C3H7NO,4.25(H2O1)
Acta Crystallographica Section C (2018) 74, 3
a=13.406(5)Å b=24.365(5)Å c=28.114(5)Å
α=90.0° β=90.0° γ=90.0°
3-Hydroxy-2-(toluene-4-sulfonylamino)-propionic acid
C10H13NO5S
Crystal Growth & Design (2014) 14, 4 1938
a=4.9709(2)Å b=9.7703(5)Å c=24.2865(13)Å
α=90.00° β=90.00° γ=90.00°